Gene Therapy. Redefined.

We are developing life-changing gene therapies for conditions affecting millions of people around the world. Our mission is to make gene therapies accessible – not just for the few – but for the many.

In Sanskrit, Kriya (“kree-yah”) means “action.” When we succeed, Kriya – in every language – will mean “gene therapy for all in need.”

Therapeutic Areas

Kriya is targeting diseases that impact millions of people worldwide and represent areas of high unmet need. We target validated biological pathways with innovative gene therapy approaches that have the potential to deliver transformative benefits.


Disease Targets


Disease Targets


Disease Targets

Kriya is led by a team of exceptional drug developers, including pioneers in the fields of gene therapy and complex biologics.

We are located in Palo Alto, California and Research Triangle Park, North Carolina.

Our Investors

We are backed by leading healthcare and technology investors who are committed to our goal of building the world’s leading gene therapy biopharmaceutical company. Since our founding in 2019, Kriya has secured over $600 million in investment.